Cargando…

Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials

AIMS: To assess the therapeutic potential of fatty acid synthase (FASN) inhibition with FT‐4101, a potent, selective, orally bioavailable, small‐molecule by (a) evaluating the dose−response of single FT‐4101 doses (3, 6 and 9 mg) on hepatic de novo lipogenesis (DNL) in healthy participants (Study 1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beysen, Carine, Schroeder, Patricia, Wu, Eric, Brevard, Julie, Ribadeneira, Maria, Lu, Wei, Dole, Kiran, O'Reilly, Terry, Morrow, Linda, Hompesch, Marcus, Hellerstein, Marc K., Li, Kelvin, Johansson, Lars, Kelly, Patrick F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898808/ https://www.ncbi.nlm.nih.gov/pubmed/33289350 http://dx.doi.org/10.1111/dom.14272

Ejemplares similares

OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption
por: Powell, David, et al.
Publicado: (2019)

Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption
por: Powell, David R, et al.
Publicado: (2019)

Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro
por: Cominguez, Divina C., et al.
Publicado: (2022)

Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice
por: Kong, Qin, et al.
Publicado: (2016)

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020)

Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan
por: SAWANO, TAKEYUKI, et al.
Publicado: (2015)

Cerulenin Blockade of Fatty Acid Synthase Reverses Hepatic Steatosis in ob/ob Mice
por: Cheng, Gang, et al.
Publicado: (2013)

Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice
por: Qiu, Ping, et al.
Publicado: (2015)

Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice
por: Cruz, Maysa M., et al.
Publicado: (2020)

Acetyl-CoA-mediated autoacetylation of fatty acid synthase as a metabolic switch of de novo lipogenesis in Drosophila
por: Miao, Ting, et al.
Publicado: (2022)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

4101 Creating a Culturally Sensitive Report Card for African American (AA) Kidney Transplant Candidates
por: McKinney, Warren, et al.
Publicado: (2020)

IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
por: Negrin, Kimberly A., et al.
Publicado: (2014)

Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood
por: Decaris, Martin L., et al.
Publicado: (2016)

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake
por: Cedó, Lídia, et al.
Publicado: (2017)

The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys
por: Singh, Sheo B., et al.
Publicado: (2016)

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and B-Cell Growth Transformation Induce Lipogenesis through Fatty Acid Synthase
por: Hulse, Michael, et al.
Publicado: (2021)

Automated assessment of steatosis in murine fatty liver
por: Sethunath, Deepak, et al.
Publicado: (2018)

Estimation of Fatty Acids in Intramuscular Fat of Beef by FT-MIR Spectroscopy
por: Beriain, María José, et al.
Publicado: (2021)

Correction: The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys
por: Singh, Sheo B., et al.
Publicado: (2017)

A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid utilization
por: Liu, Sihao, et al.
Publicado: (2013)

The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
por: Moore, J. Bernadette, et al.
Publicado: (2014)

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
por: Paglialunga, Sabina, et al.
Publicado: (2016)

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis
por: Liu, Yan, et al.
Publicado: (2018)

Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
por: Knebel, Birgit, et al.
Publicado: (2019)

FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism
por: Gökmen, Fatma Yahyaoğlu, et al.
Publicado: (2016)

Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
por: Liu, Baoqing, et al.
Publicado: (2019)

Characterization of an in vitro steatosis model simulating activated de novo lipogenesis in MAFLD patients
por: Kim, Woonghee, et al.
Publicado: (2023)

Acetyl‐coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double‐blind, crossover study
por: Stiede, Kathryn, et al.
Publicado: (2017)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease
por: Liao, Tzu-Chieh, et al.
Publicado: (2022)

Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
por: Fu, Xiaorong, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation
por: Ma, Yongjie, et al.
Publicado: (2021)

Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as “Antidiabesity” Agents Based on Repurposing and Morphing of WB-4101
por: Artasensi, Angelica, et al.
Publicado: (2022)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
por: Sanders, Francis W. B., et al.
Publicado: (2018)

MiR‐22 modulates the expression of lipogenesis‐related genes and promotes hepatic steatosis in vitro
por: Yang, Zhuo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f6tq00pr3gjaqqkp5s04jovq10